Balyasny Asset Management
TWST icon

Balyasny Asset Management’s Twist Bioscience TWST Stock Holding History

Balyasny Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$747K Sell
7,265
-719,023
-99% -$46.8M ﹤0.01% 2357
2026
Q1 		$34.5M Buy
726,288
+146,918
+25% +$6.59M 0.04% 482
2025
Q4 		$18.4M Buy
579,370
+333,134
+135% +$10.4M 0.02% 758
2025
Q3 		$6.93M Sell
246,236
-382,005
-61% -$11.6M 0.01% 1224
2025
Q2 		$23.1M Buy
628,241
+567,481
+934% +$19.6M 0.03% 613
2025
Q1 		$2.39M Buy
+60,760
New +$2.74M ﹤0.01% 1626
2024
Q4 		– Sell
-12,389
Closed -$560K – 3274
2024
Q3 		$560K Sell
12,389
-61,430
-83% -$2.92M ﹤0.01% 2213
2024
Q2 		$3.64M Buy
73,819
+19,082
+35% +$778K 0.01% 1315
2024
Q1 		$1.88M Sell
54,737
-97,891
-64% -$3.53M ﹤0.01% 1555
2023
Q4 		$5.63M Sell
152,628
-47,385
-24% -$1.1M 0.01% 1076
2023
Q3 		$4.05M Buy
200,013
+82,237
+70% +$1.81M 0.01% 1171
2023
Q2 		$2.41M Sell
117,776
-596,752
-84% -$8.94M 0.01% 1322
2023
Q1 		$10.8M Buy
714,528
+478,934
+203% +$10.6M 0.03% 743
2022
Q4 		$5.61M Buy
235,594
+955
+0.4% +$27.7K 0.02% 977
2022
Q3 		$8.27M Sell
234,639
-77,280
-25% -$3.28M 0.03% 769
2022
Q2 		$10.9M Buy
+311,919
New +$11M 0.04% 621
2021
Q1 		– Sell
-20,464
Closed -$2.89M – 2079
2020
Q4 		$2.89M Buy
+20,464
New +$2.27M 0.02% 790

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Balyasny Asset Management's TWST Position: Q2 2026 in Review

Balyasny Asset Management reduced its Twist Bioscience (TWST) stake by 99% in Q2 2026, selling an estimated $46.8M and leaving 7,265 shares worth $747K. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Balyasny Asset Management first reported a position in TWST in Q4 2020 and has held it in 17 quarters since. The position peaked at $34.5M in Q1 2026. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Balyasny Asset Management held 7,265 shares of Twist Bioscience worth $747K as of Q2 2026.
  • Balyasny Asset Management sold 719,023 Twist Bioscience shares in Q2 2026, an estimated $46.8M.
  • Twist Bioscience made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2357 holding.
  • Balyasny Asset Management first reported a position in Twist Bioscience in Q4 2020 and has held it in 17 quarters since.
  • Balyasny Asset Management's Twist Bioscience position peaked at $34.5M in Q1 2026.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.